BridgeMD
Study on the use of high-flow oxygen to improve the safety of high-risk patients during sedated digestive endoscopies
EU CTIS ID: 2026-525766-21-01
What this study is testing
To evaluate the effectiveness of administering high-flow medical oxygen during digestive endoscopic procedures under deep sedation in order to reduce episodes of hypoxemia.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age ≥ 18 years Signed informed consent Obesity (BMI ≥ 30 kg/m²) ASA physical status III Stable pulmonary disease (no hospital admission within the previous 6 months) Stable heart failure (no hospital admission within the previous 6 months) Diagnosed obstructive sleep apnea or suspected OSA defined as a STOP-Bang score ≥ 3 (Appendix II) History of sedation-related complications during a previous endoscopic procedure under deep sedation
You likely can't join if
- ASA physical status IV Acute decompensated or unstable heart failure at the time of endoscopy (hospital admission within the previous 6 months) Acute exacerbation or unstable respiratory disease at the time of endoscopy (hospital admission within the previous 6 months) Pregnant women Use of long-term home oxygen therapy Patients with orotracheal intubation Tracheostomized patients Known allergy to propofol or contraindication to its use
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.